
iRhythm Technologies, a San Francisco-based company, develops and distributes cardiac rhythm monitoring devices.
Founded in San Francisco, iRhythm Technologies focuses on developing and distributing advanced cardiac rhythm monitoring devices. Their core mission is to redefine the way cardiac arrhythmias are diagnosed, enhancing patient care through innovative technology. The company’s flagship product, the Zio monitor, is designed for patient comfort with features like waterproof housing and high breathability. iRhythm serves a diverse market including physicians, clinical staff, and patients across the United States.nniRhythm Technologies has analyzed over a billion hours of heartbeat data and published numerous peer-reviewed studies, underscoring their impact in the medical field.
Notable investors and affiliated individuals include prominent venture capital firms and experienced healthcare professionals. The company's achievements in patient compliance and data accuracy have significantly advanced cardiac care, making them a leader in the industry.

RhythmScience

AliveCor
alivecor.com

Masimo
masimo.com
Impedance Cardiology Systems

Cardiac Insight

Rhythm Management Group
myrhythmnow.com

Innerpulse

Atrility Medical
atrility.com

Cercacor Laboratories
cercacor.com

Cardiox
cardiox.com

Qardio
qardio.com

Corhythm
corhythm.com
Edwards Lifesciences
edwards.com

Pace mate
pacemate.com

ReliantHeart
reliantheart.com
Companies similar to iRhythm include RhythmScience, AliveCor, Masimo and Impedance Cardiology Systems.
iRhythm was founded in 2006.
iRhythm's headquarters is located in San Francisco, CA, US.
iRhythm's most recent funding round was for $220M (USD) in August 2020.
As of Aug 21, 2020, iRhythm has raised a total of $533.2M (USD).
iRhythm has 1,793 employees as of Feb 6, 2024.